1. Home
  2. THRM vs RAPP Comparison

THRM vs RAPP Comparison

Compare THRM & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gentherm Inc

THRM

Gentherm Inc

HOLD

Current Price

$38.75

Market Cap

1.1B

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$29.08

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
THRM
RAPP
Founded
1991
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
1993
2024

Fundamental Metrics

Financial Performance
Metric
THRM
RAPP
Price
$38.75
$29.08
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$39.00
$47.80
AVG Volume (30 Days)
169.4K
408.4K
Earning Date
02-18-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.99
N/A
Revenue
$1,468,728,000.00
N/A
Revenue This Year
$3.56
N/A
Revenue Next Year
$2.52
N/A
P/E Ratio
$39.37
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.75
$6.43
52 Week High
$41.09
$42.27

Technical Indicators

Market Signals
Indicator
THRM
RAPP
Relative Strength Index (RSI) 58.14 49.19
Support Level $35.86 $26.60
Resistance Level $37.57 $30.79
Average True Range (ATR) 0.97 1.94
MACD 0.11 -0.28
Stochastic Oscillator 71.55 38.67

Price Performance

Historical Comparison
THRM
RAPP

About THRM Gentherm Inc

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: